NEW YORK — DiamiR said on Wednesday that it has received a $492,000 grant from the Alzheimer's Drug Discovery Foundation (ADDF) to investigate the use of microRNAs as biomarkers of neurodegeneration.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.
This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.
This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.